Project Grant R43NS135862
Award Date
9/16/24
Completion Date
8/31/25
Dollars Obligated
$332K
Federal Agency
National Institute of Neurological Disorders and Stroke
Awardee
Hemex Health Inc. (LSJ7WFKBJWW4)
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Portland, OR 97238, USA
Similar Awards
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $739,772 to Cian, Inc. to develop a biomarker kit for improved diagnosis and prognosis of traumatic brain injury (TBI). The key products and services to be delivered through this 24-month award are: 1) the development of monoclonal antibodies targeting two proteins...
This Cooperative Agreement award, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, aims to conduct analytical validation of 7 emerging biomarkers for traumatic brain injury (TBI). The $2,888,616 award, with a performance period from August 2024 to July 2028, will assay existing blood samples collected from over 80 hospitals worldwide as part...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $559,820 project grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the University of South Carolina. This 5-year grant, effective January 1, 2025, will fund research to integrate advanced biomechanical measurement techniques, including dynamic MRI and sonomicrometry, to better characterize the intracranial biomechanics of traumatic brain injury (TBI). The goal...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, will fund research at the Augusta University Research Institute, Inc. (doing business as Georgia Health Sciences) to investigate the mechanisms linking traumatic brain injury (TBI) to subsequent neurodegeneration and dementia. The $1,975,262 award will support a 3-year study...
This Project Grant award, with a total funding amount of $453,860.00, was issued by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The award supports research aimed at understanding the role of metabolic regulation, particularly AMPK activation, in modulating neutrophil extracellular trap (NET) formation and inflammation following traumatic brain injury...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $1,499,886 to Astrocyte Pharmaceuticals Inc. to advance the development of an oral tablet formulation of the pharmaceutical agent AST-004 for the treatment of moderate traumatic brain injuries (TBI). The key objectives of this 2-year project are to: (1) verify the...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program provides $102,948.00 to Case Western Reserve University to investigate the link between traumatic brain injury (TBI), hematopoietic stem cell dysfunction, chronic neurodegeneration, and Alzheimer's disease (AD). The key objectives are to assess how acute TBI induces changes to...
This Project Grant award from the National Science Foundation (NSF) Engineering program (CFDA 47.041) will support research to study how astrocytes, a critical cell type in the brain, respond to mechanical forces and strain associated with traumatic brain injury (TBI). The $705,806 award to Tufts University will fund the development of controlled 3D brain-like cell culture environments and ex vivo brain cultures to quantify astrocytes' acute and chronic responses to mechanical perturbation...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Program award of $274,855 provides funding to Mito-Biotherapeutics, Inc. to develop a novel fusion protein construct (NFP) that can cross the blood-brain barrier and deliver a therapeutic payload to repair mitochondrial DNA damage in neurons following traumatic brain injury (TBI). The project aims to demonstrate NFP's technical capability to navigate to the target site, penetrate neuronal cells, and...
The U.S. Defense Health Agency has awarded a $1,395,898 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Medicortex Finland LTD for the project titled "POINT-OF-INJURY DIAGNOSIS OF TRAUMATIC BRAIN INJURY USING SALIVA". The 2-year grant, effective from June 15, 2024 to June 14, 2026, will fund research to develop a point-of-injury diagnostic tool for traumatic brain injury using saliva samples. This aligns with the program's objective of...